Mammalian metabolites of steroids

Details for Australian Patent Application No. 2010319697 (hide)

Owner Tokai Pharmaceuticals, Inc.

Inventors Chappel, Scott C.; Casebier, David S.

Agent Cullens

Pub. Number AU-A-2010319697

PCT Pub. Number WO2011/059969

Priority 61/261,262 13.11.09 US

Filing date 9 November 2010

Wipo publication date 19 May 2011

International Classifications

C07J 43/00 (2006.01) Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

7 June 2012 PCT application entered the National Phase

  PCT publication WO2011/059969 Priority application(s): WO2011/059969

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010319698-Implant power control

2010319696-Drug products and dry powder inhalers with multiple reservoirs